IDXX
IDEXX Laboratories
Is IDXX Halal?
Veterinary diagnostics are generally permissible, subject to animal-health and end-use review.
What You Should Know
IDEXX's March 31, 2026 filing shows debt/assets of 20.09%, liquidity/assets of 5.92%, receivables plus cash/assets of 23.75% and disclosed interest income/revenue of 0.05%. Veterinary diagnostics, software and water testing generally support animal health and environmental monitoring, but animal research, diagnostic inputs, customer end uses and laboratory workflows are not allocated into a universal prohibited-revenue numerator.
⚠️ Concerns
- •Veterinary diagnostics require animal-welfare, testing and product-input review
- •Water-quality and laboratory products serve mixed commercial and government workflows
- •Customer end-use revenue is not separately allocated for activity screening
- •Financial ratios pass the examined asset-based screens, but business classification remains incomplete
Current quantitative Sharia screen
Based on 10-Q figures for the period ended 2026-03-31; calculated 2026-07-14.
679.997 / 3,385.497
200.528 / 3,385.497
804.072 / 3,385.497
0.6 / 1,140.82
- Financial
- Pass
- Overall
- Incomplete
Debt/assets is 20.09%, liquidity/assets is 5.92%, receivables plus cash/assets is 23.75% and disclosed interest income/revenue is 0.05%, below the examined limits; activity classification remains incomplete.
- Financial
- Pass
- Overall
- Incomplete
Debt/assets is 20.09%, liquidity/assets is 5.92% and receivables plus cash/assets is 23.75%, below the examined MSCI total-assets limits; activity classification remains incomplete.
- Financial
- Pass
- Overall
- Incomplete
The examined ratios pass at debt/assets 20.09% and liquidity/assets 5.92%; activity classification remains incomplete and this is not an official classification.
- Financial
- Not calculated
- Overall
- Incomplete
A licensed historical market-cap series is not stored and business classification remains incomplete, so market-cap methods are not estimated from a current spot price.
Business-activity disclosure
IDEXX supplies veterinary diagnostics, software, services and water-quality testing. These activities generally support animal health and environmental monitoring, while animal research, diagnostic inputs, customer end uses and laboratory workflows require continuing qualitative review.
Limitation: The filing does not allocate revenue into a universal prohibited-activity numerator for animal testing, diagnostic ingredients, customer end uses or water and environmental workflows.
Purification
IDEXX discloses $0.6 million of interest income but does not prescribe a scholar-approved purification percentage; the disclosed ratio is evidence for the income screen, not a complete purification prescription.
Inputs, assumptions and primary sources
- Amounts are USD millions converted from the thousands presentation in IDEXX's March 31, 2026 Form 10-Q.
- Debt includes the $530.0 million credit facility and $150.0 million current portion of long-term debt; operating leases are excluded.
- Cash and cash equivalents are $200.5 million; no separate interest-bearing securities balance is identified.
- Accounts receivable, net are $603.5 million and first-quarter revenue is $1,140.8 million; disclosed interest income is $0.6 million.
- The filing does not allocate product, customer or end-use revenue into a universal prohibited-activity numerator.
This is a reproducible financial screen, not a fatwa. A failed total-assets screen can coexist with a pass under a market-cap methodology. ZakatInvest keeps the qualitative assessment separate so numerical thresholds do not erase material context.
Similar Stocks
Want to screen more assets?
Use our interactive Halal Checker to screen any stock, ETF, or crypto instantly.
Go to Halal Checker →